DISEASE INDICATIONS: Macular Degeneration

MANUFACTURER: Roche Registration Limited

USAGE: Intravitreal

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Vabysmo (faricimab-svoa) is a prescribed medication utilized for managing two of the principal causes of visual impairment – neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME).